Logo

American Heart Association

  30
  0


Final ID: MP1394

A Case of Recurrent Acute Coronary Syndrome and Cardiogenic Shock due to Apolipoprotein A-IV Amyloidosis

Abstract Body (Do not enter title and authors here): Background: Amyloidosis occurs when endogenous circulating proteins misfold and are deposited in various tissues, including the myocardium. Apolipoprotein A-IV (Apo-AIV) amyloidosis is a rare form of this condition caused by deposition of amyloid proteins in the heart, kidney, and duodenum.
Case Presentation: A 78-year-old male patient with coronary artery disease and prior ST elevation myocardial infarction, prior two vessel coronary artery bypass surgery, chronic systolic heart failure, and chronic kidney disease presented initially with dyspnea on exertion and angina concerning for myocardial infarction, with no culprit lesion identified on angiography. He underwent cardiac MRI and endomyocardial biopsy which was consistent with ApoAIV amyloidosis. He was readmitted with acute angina and extreme elevation in coronary biomarkers, but repeat coronary angiography again did not show a culprit lesion. Right heart catheterization revealed cardiogenic shock, and he required intra-aortic balloon pump support.
Discussion: Cardiac amyloidosis commonly presents with diastolic heart failure and/or conduction abnormalities. ApoAIV amyloidosis is a rare form of amyloidosis whose clinical presentation is not very well characterized. This case highlights a rare manifestation of cardiac amyloidosis with acute coronary syndrome without changes in the epicardial coronary arteries. Instead, myocardial infarction was likely caused by microvascular coronary changes. Amyloidosis can less commonly cause obstruction of the coronary microvasculature which can lead to angina and ischemic changes as seen in this patient.
Conclusion: ApoAIV amyloidosis is a rare form of cardiac amyloidosis. It is important to maintain a high index of suspicion for microvascular dysfunction and/or obstruction from amyloidosis that can lead to clinical syndromes of myocardial ischemia and infarction.
  • Muthukkumar, Rashmi  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Holmes, Taylor  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Friede, Kevin  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Author Disclosures:
    Rashmi Muthukkumar: DO NOT have relevant financial relationships | Taylor Holmes: No Answer | Kevin Friede: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Clinical Case: Heart Failure and Cardiomyopathy

Sunday, 11/09/2025 , 11:50AM - 01:05PM

Moderated Digital Poster Session

More abstracts on this topic:
A human cardiomyocyte model of CD36 haploinsufficiency uncovers fatty acid oxidation deficits driving dilated cardiomyopathy

Al Sayed Zeina, Klattenhoff Carla, Aragam Krishna, Ellinor Patrick, Willcox Jon, Zheng Alice, Koledova Vera, Srivastava Salil, Yin Xiaofei, Chaffin Mark, Rigaud Vagner, Kovacs-bogdan Erika

A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial

May Heidi, Colipi Dominique, Whiting Tyler, Muhlestein Joseph, Le Viet, Anderson Jeffrey, Babcock Daniel, Wayman Libby, Bair Tami, Knight Stacey, Knowlton Kirk, Iverson Leslie

You have to be authorized to contact abstract author. Please, Login
Not Available